The prevalence of type 2 diabetes is rising globally, with a disproportionate impact on individuals in low-income and middle-income countries, where access to care and new therapies is often limited.

The pharmaceutical industry is key and needs to focus resources on promoting development to keep pace with modern medical ...

Following results that have sent the stock northward, Research Capital analyst Andre Uddin remains bullish on Eupraxia ...

The expansion of the advanced therapy medicinal products market is primarily fueled by the increasing incidence of chronic diseases. The risi ...